JPRN-jRCT1091220030已完成2 期
Docetaxel and S-1 treatment for patients with metastatic breast cancer - KBCOG 07
Kobe Breast cancer Oncology Group (KBCOG)0 个研究点目标入组 40 人开始时间: 2009年8月13日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 < 75age old（—）
- 性别
- All
入选标准
- •1.Histologically or cytologically proven as breast cancer
- •2.Metastatic or recurrent breast cancer
- •3.Four weeks after the last administration of endcrine therapy
- •4.One year after the last administration of Docetaxel
- •5.Two weeks after the radiation therapy
- •6.Performance Status:0?2
- •7.Age 20 to 74 year old
排除标准
- •1.Suspected infection
- •2.Abundant of pleural effusion and ascites
- •3.Simultaneous or metachronous (within 5 years) double cancers , with the exception of intramucosal tumor curable with local therapy
- •4.Decetaxel resistant
- •5.Grade 2 edema
- •6.Interstitial pneumonia
- •7.Brain metastasis with clinical manifestation
- •8.HB antigen positive
- •9.HER 2 positive
- •10.Pregnant or lactating women or women of childbearing potential
研究者
相似试验
进行中（未招募）
1 期
Phase II Trial of Docetaxel in Patients With Metastatic or Inoperable Medullary Thyroid CancerMetastatic or inoperable medullary thyroid cancerEUCTR2006-005301-63-ATniversity Hospital Vienna
已完成
2 期
Docetaxel and S-1 as adjuvant chemotherapy for pathological stage II, IIIA, IIIB gastric cancerPathological stage II, IIIa, or IIIb gastric cancerJPRN-UMIN000000857Dept. of Surgery and Science, Kyushu University20
已完成
1 期
Phase I/II Study of Docetaxel and S-1 Combination Therapy for Advanced Non-small Cell Lung CancerJPRN-C000000281The Tokyo Cooperative Oncology Group60
已完成
2 期
Phase II Study of Docetaxel and S-1 Combination Therapy for Advanced or Recurrent Gastric CancerMetastatic gastric cancer (Advanced or recurrent gastric cancer)JPRN-C000000103Hiroshima Cancer Therapy Development Organization (HiCTDO)50
暂停
2 期
A Phase II trial of S-1 and Docetaxel followed by FEC as neoadjuvant chemotherapy for primary breast cancerBreast CancerJPRN-UMIN000005100Keio University School of Medicine40